20 June 2022 : Clinical Research
A Single-Center Retrospective Study to Compare the Efficacy and Safety of Modified FOLFIRINOX with S-1 as Adjuvant Chemotherapy in 71 Patients with Resected Pancreatic Carcinoma
DOI: 10.12659/MSM.937136
Med Sci Monit 2022; 28:e937136